ReviewJournal of hepatocellular carcinoma2019

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives.

Li-Chun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.